Nasdaq:US$18.56 (+0.55) | HKEX:HK$29.05 (+0.55) | AIM:£2.92 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF